| Study Period | 2020 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 623.08 Million |
| Market Size (2030) | USD 812.28 Million |
| CAGR (2025 - 2030) | 5.45 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
United States House Call Market Analysis
The United States House Call Market size is estimated at USD 623.08 million in 2025, and is expected to reach USD 812.28 million by 2030, at a CAGR of 5.45% during the forecast period (2025-2030).
In the United States, the house call market is being driven by government initiatives aimed at improving physician payment models, the expanding geriatric population, and the increasing prevalence of chronic diseases.
The growing burden of chronic diseases is a significant factor contributing to the rise in house call services across the country. For instance, the American Cancer Society (ACS) reported in 2023 that cancer diagnoses exceeded 1.96 million cases, reflecting an increase of over 60,000 cases within two years. This trend highlights the rapid escalation of cancer incidences nationwide.
Additionally, the ACS attributes the rising number of annual cancer diagnoses primarily to the aging and growing population. The likelihood of developing cancer increases significantly with age, with projections indicating that 93% of new cancer cases in males and 87% in females will occur in Canadians aged 50 years and older. The increasing prevalence of cancer among the aging population drives the demand for accessible and patient-centric healthcare solutions, thereby propelling the growth of the United States house call market.
Similarly, a February 2024 report from the National Center for Health Statistics revealed that in 2022, the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older stood at 18.9%. Women exhibited a higher prevalence rate of 21.5% compared to 16.1% in men. The prevalence rose sharply with age, from 3.6% among individuals aged 18–34 to 53.9% in those aged 75 and older. This increasing prevalence, particularly among older adults with mobility limitations, is anticipated to drive the demand for house call services in the United States, providing a convenient healthcare solution for managing chronic conditions such as arthritis.
Furthermore, growing government support and funding initiatives are accelerating the integration of precision medicine into healthcare systems. Strategic investments are fostering research and the implementation of precision medicine approaches, addressing conditions such as cardiovascular diseases and rare genetic disorders, thereby contributing to the growth of the regional market.
For instance, in January 2024, The Mercy Hospital-at-Home program was launched in St. Louis to integrate acute care services traditionally provided in hospitals into a home-based setting. This program employs both in-person and virtual healthcare delivery methods and is managed by a multidisciplinary team. Patients are equipped with essential medical equipment, medications, and therapies upon discharge. This innovative approach is expected to significantly contribute to the growth of the house call market in the United States by expanding access to comprehensive, patient-centered care within the home environment.
In summary, the growth of the house call market in the United States is being driven by the increasing prevalence of chronic diseases, the aging population, and government initiatives aimed at enhancing home-based healthcare delivery to provide accessible, patient-centered care. However, certain challenges within the United States may hinder market growth during the forecast period.
United States House Call Market Trends
The Mobile Clinical Testing Segment is Expected to Register a Significant Share of the Market Over the Forecast Period
Demographic trends, including an aging population, escalating healthcare expenditures, and a heightened preference for personalized care, are driving significant growth in the U.S. house call market. A particularly dynamic segment within this market is the expansion of mobile clinical testing services. These services provide diagnostic tests and screenings directly at patients' residences, leveraging portable medical devices operated by healthcare professionals. This model emphasizes flexibility and a patient-focused approach to healthcare delivery.
The aging population in the United States is a key factor contributing to the expansion of mobile clinical testing services. A substantial portion of older adults manage chronic conditions such as diabetes, heart disease, and respiratory disorders, creating a clear demand for convenient and continuous monitoring. For example, a January 2024 study by the Pew Research Center, based on projections from the U.S. Census Bureau, indicates that the number of Americans aged 100 and older is expected to increase from approximately 101,000 in 2024 to around 422,000 by 2054, representing a more than fourfold rise over three decades. While centenarians currently account for just 0.03% of the U.S. population, this figure is projected to reach 0.1% by 2054.
Furthermore, the same study highlights that approximately 62 million adults aged 65 and older currently reside in the United States, comprising 18% of the population. By 2054, this demographic is anticipated to grow to 84 million, representing an estimated 23% of the population. This projected increase, particularly among centenarians, is driving the demand for mobile clinical testing services within the U.S. house call market. These services address the need for accessible healthcare solutions tailored to the requirements of older adults. By reducing the necessity for frequent hospital visits, mobile testing services enable regular monitoring, improve patient outcomes, and contribute to cost efficiencies in healthcare delivery.
Technological advancements have been instrumental in the growth of mobile clinical testing services. The development of advanced portable medical devices has facilitated accurate diagnostic testing in non-clinical settings, ensuring reliable results outside traditional healthcare environments. Additionally, the integration of digital health technologies—such as remote monitoring, data sharing, and real-time communication between patients and healthcare providers—has enhanced accessibility and convenience. Telehealth further complements these services by enabling virtual consultations and the interpretation of test results, thereby improving overall service delivery.
For instance, in February 2023, Co-Diagnostics, Inc., a molecular diagnostics company with a proprietary platform for developing diagnostic tests, initiated clinical evaluations for its Co-Dx PCR Home platform and its initial COVID-19 test. These evaluations, which include clinical trials and analytical studies, are designed to support regulatory submissions to the U.S. FDA and other authorities. This development is expected to drive growth in the mobile clinical testing segment of the U.S. house call market by increasing the availability of efficient, at-home diagnostic solutions.
In conclusion, the U.S. house call market is experiencing notable growth, with mobile clinical testing services emerging as a key driver. This expansion is primarily attributed to an aging population, advancements in technology, and an increasing demand for personalized healthcare solutions.
Understand The Key Trends Shaping This Market
Download PDF
The Chronic Segment is Expected to Register a Significant Share of the Market Over the Forecast Period
The house call market in the United States is experiencing growth driven by the increasing prevalence of chronic diseases, the strong presence of key industry players, and a rise in acquisitions and product launches.
Heart disease, in particular, is anticipated to significantly contribute to market expansion. For instance, a study published by the Centers for Disease Control and Prevention (CDC) in October 2024 reported that in 2022, a heart attack occurred every 40 seconds in the United States. Of the 805,000 annual heart attacks, 605,000 were first-time occurrences, while 200,000 involved individuals with a prior history of heart attacks. This growing prevalence of heart disease is expected to drive demand for healthcare services, particularly within the chronic disease segment of the house call market, as patients increasingly opt for the convenience of at-home care solutions.
Similarly, hypertension remains a significant health concern. According to the same CDC study, between August 2021 and August 2023, the prevalence of adult hypertension was 47.7%, with higher rates observed in men (50.8%) compared to women (44.6%). The prevalence also increased with age, affecting 23.4% of individuals aged 18–39, 52.5% of those aged 40–59, and 71.6% of individuals aged 60 and older. This rising incidence of hypertension, particularly among older adults, is projected to bolster the demand for chronic disease management services, thereby driving growth in the chronic disease segment of the U.S. house call market.
Additionally, companies are increasingly adopting strategies such as collaborations, acquisitions, business expansions, and new product launches to strengthen their market position. For instance, in January 2023, the National Institutes of Health, in partnership with the Administration for Strategic Preparedness and Response (ASPR), introduced the Home Test to Treat program, a fully virtual community health initiative offering free COVID-19 health services, including at-home rapid tests, telehealth consultations, and treatments. Announced by the White House in September 2022, the program aims to provide antiviral treatment to eligible individuals who test positive, potentially preventing severe illness, hospitalization, or death. This initiative is expected to accelerate the growth of the house call market in the United States by expanding the demand for remote healthcare services and facilitating more widespread use of at-home medical treatments.
In conclusion, the increasing prevalence of chronic diseases, strategic initiatives by companies, and the growing demand for at-home healthcare services are key factors anticipated to significantly drive the expansion of the chronic disease segment within the United States house call market.
Get Analysis on Important Geographic Markets
Download PDF
United States House Call Industry Overview
The United States house call market is moderately consolidated due to a few large companies dominating most of the market share, including Concierge MD, Doctors House Calls, Ennoble Care, Housecall Doctors Medical Group, and among others.
United States House Call Market Leaders
-
Concierge MD
-
Doctors House Calls
-
Ennoble Care
-
Housecall Doctors Medical Group
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
United States House Call Market News
- April 2024: The FDA launched the Home as a Health Care Hub initiative to reimagine the home as an integral part of the health care system, aimed at advancing health equity by incorporating home-based care solutions. This initiative includes the development of an AR/VR-enabled prototype in collaboration with healthcare providers, patient groups, and the medical device industry.
- January 2024: Eli Lilly and Company introduced LillyDirect, a digital healthcare platform designed to provide U.S. patients with obesity, migraine, and diabetes access to personalized disease management resources, healthcare providers, and home delivery of select Lilly medications through third-party pharmacy services.
United States House Call Industry Segmentation
As per the scope of the report, a medical house call involves a healthcare professional visiting a patient’s home to deliver services such as diagnosis, treatment, and medication management. This approach is gaining popularity due to the aging population’s mobility challenges and the growing emphasis on personalized, comprehensive care by providers.
The United States house call market is segmented by services and condition type. The services segment is further divided into mobile clinical testing, primary care, preventive care, and other services. The condition type segment is further segmented into acute, chronic, and emergency. The report offers the value (in USD) for the above segments.
| By Services | Mobile Clinical Testing |
| Primary Care | |
| Preventive Care | |
| Other Services | |
| By Condition Type | Acute |
| Chronic | |
| Emergency |
Need A Different Region or Segment?
Customize Now
United States House Call Market Research FAQs
How big is the United States House Call Market?
The United States House Call Market size is expected to reach USD 623.08 million in 2025 and grow at a CAGR of 5.45% to reach USD 812.28 million by 2030.
What is the current United States House Call Market size?
In 2025, the United States House Call Market size is expected to reach USD 623.08 million.
Who are the key players in United States House Call Market?
Concierge MD, Doctors House Calls, Ennoble Care and Housecall Doctors Medical Group are the major companies operating in the United States House Call Market.
What years does this United States House Call Market cover, and what was the market size in 2024?
In 2024, the United States House Call Market size was estimated at USD 589.12 million. The report covers the United States House Call Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the United States House Call Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
